ArticleInternational journal of clinical and experimental pathology2019

Decitabine reverses gefitinib resistance in PC9 lung adenocarcinoma cells by demethylation of RASSF1A and GADD45β promoter.

Tao Hou et al.PubMed ↗Full text ↗

No numbers read from the abstract.